Mindrank AI CEO discusses AI drug discovery strategy
Niu Zhangming, founder and CEO of AI biotech firm Mindrank AI, discussed the company's business strategy and AI's role in drug discovery at the Asia Innovation and Technology Enterprises Going Global Summit in Hong Kong.
Featured · Niu Zhangming
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- ChatGPT users complain it forces local language despite English setting
- New methods steer recurrent reasoners at inference time
- Tencent releases WeMM-Embedding multimodal embedding models
- FireRedTeam releases FireRedAudio and FireRedTTS3
- Minimax H3 image-to-video demo: Better Avoid Saul 3